National Cancer Institute (NCI)
IRB
Details
Info
08-005
IBCSG-24-02 A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer (SOFT)
